MindWalk Holdings Corp.
HYFT Nasdaq Pharmaceutical Preparations 金融 FY2020–FY2026
MindWalk Holdings Corp. 的业务
暂无业务介绍。
- 法定名称
- MindWalk Holdings Corp.
- 财年结束日
- 2026年4月30日
- 最新年报
- 20-F · 2026年7月23日
- 登记号 · CIK
- 0001193125-26-312694
0001715925
营收与利润率
MindWalk Holdings Corp. 在 2026 财年 营收为 $11.3M,同比增长 47.9%。
净利润与每股收益
亏损期间以红色显示。
资本回报率
税后营业利润占投入业务资金(债务加股东权益减现金)的比例。
现金流
2026 财年 的自由现金流为 −$9.3M,占营收的 −82.7%。 经营现金流减资本支出。
股息、回购与股数
MindWalk Holdings Corp. 在 2026 财年 向股东返还 —。 稀释股数增加 38.9%。
资产负债表
现金、债务以及显示 MindWalk Holdings Corp. 承担债务能力的指标。
| 财年末 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| 现金及短期投资 | $23.6M | $6.1M | $2.6M | $7.8M | $8.4M |
| 流动比率 | 4.0x | 2.8x | 1.4x | 2.1x | 2.8x |
| 速动比率 | 3.9x | 2.5x | 1.2x | 1.8x | 2.7x |
| 总资产 | $73.5M | $57.0M | $43.8M | $32.1M | $15.6M |
| 总负债 | $14.4M | $14.7M | $17.8M | $15.1M | $7.0M |
| 股东权益 | $59.1M | $42.9M | $26.1M | $17.1M | $8.6M |
| 净债务 (− = 净现金) | — | — | — | — | — |
内部人交易
高管、董事和持股超过 10% 的股东在公开市场的买卖,数据来自 Form 4 申报。“计划”表示依据事先制定的 Rule 10b5-1 计划进行的交易。
买入(12 个月)
$0.0M
0 名内部人士
卖出(12 个月)
$0.0M
0 名内部人士
卖出中按计划执行的比例
—
$0.0M
过去 12 个月没有公开市场的内部人交易。
Piotroski F 分数
关于盈利能力、融资和效率的九项通过/未通过测试。8–9 为强,0–2 为弱。
| 测试项 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| 净利润为正 | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ |
| 经营现金流为正 | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ |
| 资产回报率上升 | — | ✓ | ✕ | ✕ | ✕ | ✕ | ✓ |
| 经营现金流高于净利润 | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 债务相对资产下降 | — | — | — | — | — | — | — |
| 流动比率上升 | — | ✓ | ✕ | ✕ | ✕ | ✓ | ✓ |
| 股数未增加 | — | ✕ | ✕ | ✕ | ✕ | ✕ | ✕ |
| 毛利率上升 | — | ✓ | ✕ | ✕ | ✕ | ✓ | ✓ |
| 营收相对资产上升 | — | ✕ | ✕ | ✓ | ✕ | ✓ | ✓ |
| F 分数 | — / 3 | 4 / 8 | 1 / 8 | 2 / 8 | 1 / 8 | 4 / 8 | 5 / 8 |
| 应计比率 | −13.5% | −13.9% | −8.5% | −7.7% | −33.7% | −45.0% | −4.5% |
| Altman Z'' | — | — | — | — | — | — | — |
7 年数据
金额单位为 USD。将鼠标悬停在指标名称上可查看定义。
| 财年 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| 利润表 | |||||||
| 营收 | $10.5M | $13.7M | $15.4M | $15.5M | $7.6M | $7.6M | $11.3M |
| 毛利 | $6.0M | $8.8M | $8.8M | $8.7M | $3.0M | $4.1M | $6.6M |
| 研发支出 | $0.3M | $1.5M | $6.1M | $10.6M | $2.8M | $3.0M | $3.6M |
| 利息支出 | $0.1M | $0.6M | $0.8M | $0.6M | $0.3M | $0.1M | $0.3M |
| 税前利润 | −$4.0M | −$4.6M | −$12.6M | −$20.9M | −$23.8M | −$27.0M | −$11.3M |
| 所得税 | −$0.3M | $1.0M | $0.7M | −$0.9M | −$2.1M | −$3.2M | −$0.3M |
| 净利润 | −$3.7M | −$5.6M | −$13.3M | −$20.0M | −$19.3M | −$21.7M | −$10.1M |
| 稀释每股收益 | −$0.27 | −$0.34 | −$0.68 | −$0.80 | −$0.76 | −$0.65 | — |
| 稀释股数 | 0.01B | 0.02B | 0.02B | 0.02B | 0.03B | 0.03B | 0.05B |
| 现金流 | |||||||
| 经营现金流 | −$1.0M | −$0.5M | −$7.9M | −$14.9M | −$2.4M | −$4.6M | −$9.0M |
| 资本支出 | $0.3M | $1.1M | $0.8M | $1.1M | $1.0M | $0.6M | $0.3M |
| 自由现金流 | −$1.3M | −$1.5M | −$8.8M | −$16.0M | −$3.4M | −$5.2M | −$9.3M |
| 折旧与摊销 | $1.9M | $2.1M | $2.0M | $5.0M | $4.2M | $3.7M | $1.2M |
| 股权激励 | $0.6M | $2.1M | $2.5M | $1.5M | $1.1M | $0.3M | $0.9M |
| 资产负债表 | |||||||
| 现金及短期投资 | $1.9M | $34.1M | $23.6M | $6.1M | $2.6M | $7.8M | $8.4M |
| 总债务 | $0.2M | — | — | — | — | — | — |
| 流动资产 | $5.6M | $39.8M | $29.4M | $12.3M | $8.4M | $13.6M | $11.9M |
| 流动负债 | $5.7M | $4.9M | $7.3M | $4.3M | $5.9M | $6.5M | $4.2M |
| 存货 | $0.6M | $1.0M | $1.3M | $1.5M | $1.6M | $1.5M | $0.4M |
| 固定资产净额 | $2.2M | $3.3M | $8.2M | $7.6M | $12.2M | $11.4M | $3.0M |
| 商誉 | $5.7M | $6.3M | $15.4M | $14.1M | $5.6M | $6.0M | $0.0M |
| 无形资产 | $6.0M | $4.9M | $25.4M | $22.7M | $17.2M | $0.8M | $0.0M |
| 总资产 | $19.7M | $54.5M | $73.5M | $57.0M | $43.8M | $32.1M | $15.6M |
| 总负债 | $8.8M | $8.2M | $14.4M | $14.7M | $17.8M | $15.1M | $7.0M |
| 股东权益 | $10.9M | $46.4M | $59.1M | $42.9M | $26.1M | $17.1M | $8.6M |
| 利润率 | |||||||
| 毛利率 | 57.1% | 64.4% | 56.7% | 56.0% | 39.8% | 53.9% | 58.8% |
| 净利率 | −35.2% | −41.0% | −86.3% | −128.5% | −254.1% | −284.5% | −89.7% |
| 自由现金流利润率 | −12.6% | −11.0% | −56.7% | −103.2% | −44.6% | −67.8% | −82.7% |
| 回报率 | |||||||
| 股本回报率 | −34.0% | −19.6% | −25.3% | −39.2% | −56.1% | −100.5% | −78.7% |
| 资产回报率 | −18.8% | −15.1% | −20.8% | −30.6% | −38.4% | −57.1% | −42.3% |
| 有形股本回报率 | — | −16.0% | −72.9% | −323.7% | −597.2% | −209.3% | −117.6% |
| 增长 | |||||||
| 营收增长 | — | 30.0% | 12.8% | 0.7% | −51.0% | 0.1% | 47.9% |
| 股数变化 | — | 20.9% | 19.5% | 26.5% | 3.0% | 30.2% | 38.9% |
| 财务健康 | |||||||
| 债务 / 股东权益 | 0.0x | — | — | — | — | — | — |
| 流动比率 | 1.0x | 8.0x | 4.0x | 2.8x | 1.4x | 2.1x | 2.8x |
| 速动比率 | 0.9x | 7.8x | 3.9x | 2.5x | 1.2x | 1.8x | 2.7x |
| 资本配置 | |||||||
| 资本支出 / 营收 | 2.7% | 7.7% | 5.5% | 7.2% | 13.6% | 7.5% | 2.6% |
| 股权激励 / 营收 | 5.3% | 15.3% | 15.9% | 9.4% | 14.9% | 4.2% | 8.2% |
| 质量评分 | |||||||
| Piotroski F 分数 | — | 4.0 | 1.0 | 2.0 | 1.0 | 4.0 | 5.0 |
| 应计比率 | −13.5% | −13.9% | −8.5% | −7.7% | −33.7% | −45.0% | −4.5% |
来源:SEC EDGAR XBRL 文件 (CIK 0001715925). 数据更新于 2026年10月24日。 第四季度数据为全年减去前九个月。 以 CAD 按 IFRS 申报,并换算为美元:损益和现金流项目按各期平均汇率换算,资产负债表项目按期末汇率换算。 仅供参考,不构成投资建议。依赖任何数字前,请核对原始文件。
